Cole Harris Sterling, M.D.

Headshot of Cole Harris Sterling
  • Assistant Professor of Oncology


Bone Marrow Transplant, Chronic Lymphoblastic Leukemia, Cutaneous Lymphoma, Hematologic Malignancies, Hodgkin's Disease, Lymphoma, Medical Oncology, Non-Hodgkin's Lymphoma (NHL) more

Research Interests

Lymphoma; Bone Marrow Transplantation

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment


Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Appointment Phone: 410-955-8893
401 N. Broadway
Harry and Jeanette Weinberg Building
Baltimore, MD 21231
Phone: 410-614-9193 | Fax: 410-955-0960
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center - Google Maps


Dr. Sterling is an oncologist who cares for patients with hematologic malignancies at the Johns Hopkins University School of Medicine. He is an active clinician with expertise in lymphoma and bone marrow transplantation and serves as the Director of the Johns Hopkins Lymphoma and Myeloma Multidisciplinary Conference.

Dr. Sterling earned his undergraduate degree in biomedical sciences from Auburn University and his medical degree from Johns Hopkins University. He completed his training in internal medicine and medical oncology at Johns Hopkins before being recruited to the faculty.

As a clinical investigator, Dr. Sterling's research focuses on the development of new technologies, therapies, and treatment strategies for lymphoma and other conditions treated with bone marrow transplantation. more


  • Assistant Professor of Oncology

Departments / Divisions



  • MD; Johns Hopkins University School of Medicine (2017)


  • Medicine; Johns Hopkins University School of Medicine (2020)


  • Oncology; Johns Hopkins University School of Medicine (2022)

Board Certifications

  • American Board of Internal Medicine (Internal Medicine) (2020)
  • American Board of Internal Medicine (Medical Oncology) (2022)

Research & Publications

Selected Publications

Sterling CH, Tsai HL, Holdhoff M, Bolaños-Meade J, Luznik L, Fuchs EJ, Huff CA, Gocke CB, Ali SA, Borrello IM, Varadhan R, Jones RJ, Gladstone DE, Ambinder RF, Wagner-Johnston N, Swinnen LJ, Imus PH. Allogeneic blood or marrow transplant with non-myeloablative conditioning and high dose cyclophosphamide-based graft-versus-host disease prophylaxis for secondary central nervous lymphoma. Transplant Cell Ther. 2021;27(10):863.e1-863.e5. 

Sterling C, Webster C. Harnessing the Immune System After Allogenic Stem Cell Transplant in Acute Myeloid Leukemia. Am J Hematol. 2020;95(5):529-547

Hughes MS, Sterling CH, Varadhan R, Ambinder RF, Jones RJ, Sweren RJ, Rozati S, Bolaños Meade J, Luznik L, Imus PH, Ali SA, Borrello IM, Huff CA, Jain T, Ambinder A, DeZern AE, Gocke CB, Gladstone DE, Swinnen LJ, Wagner-Johnston ND, Fuchs EJ. Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study. Leukemia & Lymphoma. Published online 01 Aug 2022. DOI: 10.1080/10428194.2022.2105330

Sterling CH, Hughes MS, Tsai HL, Yarkony K, Fuchs EJ, Swinnen LJ, Paul S, Bolaños-Meade J, Luznik L, Imus PH, Ali SA, Jain T, Ambinder A, DeZern A., Huff CA, Gocke CB, Varadhan R, Wagner-Johnston N, Jones RJ, Ambinder RF. Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source. Transplant Cell Ther. 2022; S2666-6367(22)01835-8.

Contact for Research Inquiries

1650 Orleans Street
CRB1 Room 2M11
Baltimore, MD 21287 map

Activities & Honors


  • Conquer Cancer Young Investigator Award, American Society of Clinical Oncology, 2022
  • Director's Teaching Award in Clinical Science, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 2023


  • American Society of Hematology, 2016
  • American Society of Clinical Oncology, 2016
Is this you? Edit Profile
back to top button